Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Inflammatory bowel disease (IBD) is a group of chronic relapsing disorders whose etiology has not been fully explained. Therefore, available therapeutic approaches for IBD patients are still insufficient. Current treatment strategies are targeted to immune system dysfunctions, often associated with alternations in the microbiota, which contribute to the development of chronic intestinal inflammation. Therapeutics include anti-inflammatory drugs such as aminosalicylates and corticosteroids, immunosuppressive agents, antibiotics, and biological agents such as infliximab and vedolizumab. Auxiliary therapies involve a balanced and personalized diet, healthy lifestyle, avoiding stress, as well as dietary supplements. In this review, we discuss the use of bovine colostrum (BC) as a therapeutic agent, including its advantages and contraindications. We summarize our knowledge on well-researched BC constituents and their effects on the gastrointestinal tract as evidenced in in vitro and in vivo studies. © The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.


Michał Sienkiewicz, Patrycja Szymańska, Jakub Fichna. Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications. Advances in nutrition (Bethesda, Md.). 2021 Mar 31;12(2):533-545

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33070186

View Full Text